JPI InvestFranΓ§ais
JPI AI Analyst AI assistant Β· JPI Invest
Answers based on the tool's data Β· not financial advice Β· full analysis (free)
All stocks β€Ί Health Care β€Ί WAT

Are analysts right about Waters Corporation (WAT)?

Health Care Β· price $421 Β· median target $420 (-0%)
In short β€” Over the past 12 months, 17% of analyst price targets on Waters Corporation turned out profitable, for an average return of -6% (across 70 timestamped calls). The current consensus is "Buy" with a median price target of $420 (-0% vs the current $421, from 15 analysts).

πŸ“ˆ See the interactive version (live chart) β†’

πŸ”— Related pages on Waters Corporation β€” Financials & fundamentals  Β·  If I had invested
Current price
$421
Median target (12 mo)
$420 -0%
Analyst accuracy (1 yr)
17%
Avg return / call (1 yr)
-6%
πŸ’° Performance & Β« if I invested Β» πŸ“Š Interactive analysis

Historical analyst accuracy

For Waters Corporation, we replayed every analyst price target of the past 12 months and measured the real outcome: 17% were profitable, average return -6% (70 calls). At 3 months: -2% average return (34% profitable). The higher the %, the more often analysts were right on this stock.

Most reliable analysts on this stock (past track record)

Their past track record on this stock (targets replayed against real prices) β€” not a forecast of what will happen.

Analyst / brokerCalls i% profitable iAvg return i
Barclays2119%-6%
Baird911%+3%
Wells Fargo812%-15%
Morgan Stanley520%+2%

Valuation

Is Waters Corporation overvalued, and is it a good time to buy Waters Corporation right now? If you're wondering, here's a recap to make up your own mind: Waters Corporation's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.

The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β€” but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.

MetricWaters CorporationSector median (Health Care)
P/E105.329.4
Forward P/E25.517.1
Net margin4%12%

πŸ‘‰ Waters Corporation trades above its sector median (105.3 vs 29.4) β€” the market expects higher growth; watch out for disappointment.

πŸ“– P/E, PEG, margin…: see the glossary

Frequently asked questions

Is Waters Corporation a buy right now?

The analyst consensus on Waters Corporation (WAT) is "Buy" (16 bullish, 0 bearish calls over 12 months). This is not advice: historically, 17% of their targets on this stock turned out profitable over 1 year.

What is Waters Corporation's price target?

The median 12-month price target is $420 (-0% vs $421), ranging from $330 to $475 (15 analysts).

Are analysts accurate on Waters Corporation?

Over 1 year, 17% of analyst targets on Waters Corporation were profitable, for an average return of -6% (across 70 timestamped calls). This is JPI Invest's accuracy metric.

What is the Waters Corporation stock forecast?

Analysts target a median of $420 within 12 months, i.e. -0% vs the current price. The most bullish targets $475, the most cautious $330.

What is the Waters Corporation stock forecast for 2026 or long term (2030)?

Note: analyst targets are 12-month (median $420, -0%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (17%), and the stock's past trajectory.

Is Waters Corporation overvalued?

Its P/E is 105.3, forward P/E 25.5. A forward P/E lower than the current P/E means earnings are expected to grow.

πŸ“Š See the full interactive analysis of Waters Corporation β†’

What is JPI Invest?

JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β€” on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.

Explore JPI Invest for free β†’ How it works: the method β†’

⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.